Shan Wu, Ph.D.

Shan Wu joined Viridian in 2023 and serves as its Chief Business Officer. She brings extensive experience in the biopharmaceutical industry with a strong track record in business development, corporate strategy, communications, and operations.

Most recently, Shan served as Vice President and head of business development, investor relations, and alliance management at Magenta Therapeutics. She joined Magenta at launch and helped to build it from its scientific platform to a clinical-stage company. Shan led multiple value-creating transactions at Magenta, supported private and public financings including the company’s IPO, and helped to close Magenta’s merger with Dianthus Therapeutics. Prior to Magenta, Shan was at Biogen where she led strategic forecasting for the multiple sclerosis global commercial organization.

Previously, Shan was a management consultant at Clarion Healthcare where she led projects in therapeutic area strategy, product differentiation strategy, market opportunity assessment, and global launch planning for biopharma clients. Shan holds a Ph.D. in Biological Engineering from the Massachusetts Institute of Technology and a B.S. in Computer and Electrical Engineering from the University of Virginia.